title: Clinical characteristics of facial keloids treated with surgical excision followed by intra- and postoperative intralesional steroid injections.
abstract: BACKGROUND
  The physiopathogenesis of keloid scars is not well understood. This report aims to present the authors' experiences with facial keloids, to evaluate their treatment outcomes via a prospective study, and to identify risk factors involved in facial keloid recurrence.
  
  
  METHODS
  Patients with facial keloids were treated with surgical excision followed by intra- and postoperative intralesional steroid injections at Kangbuk Samsung Hospital between July 2005 and June 2010. Of 15 keloids, 8 (53.3%) had previously been treated unsuccessfully at other hospitals. The follow-up period was 18 months, and therapeutic outcomes were evaluated based on recurrence or nonrecurrence.
  
  
  RESULTS
  The study evaluated 17 facial keloids in 15 patients. The overall recurrence-free rate was 76.5% after a follow-up period of 18 months. The authors hypothesized that the recurrence of keloids on the face is associated with both previous treatment and anatomic location.
  
  
  CONCLUSIONS
  The authors' protocol resulted in successful outcomes for the treatment of facial keloids. Patients with a history of previous treatment and keloids in the perioral region should be monitored closely for signs of recurrence and managed cautiously during treatment.
authors: Department of Plastic and Reconstructive Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 108 Pyung-Dong, Jongno-Gu, Seoul, 110-746, Korea.
authors: Tae Hwan
authors: TH
authors: Park
authors: Sang Won
authors: SW
authors: Seo
authors: June-Kyu
authors: JK
authors: Kim
authors: Choong Hyun
authors: CH
authors: Chang
mesh_terms: D000328:Adult; D005145:Face; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D015552:Injections, Intralesional; D007627:Keloid / Q000188:drug therapy* / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012008:Recurrence; D012307:Risk Factors; D014221:Triamcinolone / Q000008:administration & dosage*; D055815:Young Adult
chemical_list: D005938:Glucocorticoids; D014221:Triamcinolone